SEC Form 4 · accession 0001209191-15-078178
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Stuart
Officer — Chief Operating Officer
Period of report
Nov 2, 2015
Accepted (ET)
Nov 3, 2015 · 6:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2015 | M | 23,216 | $0.57 | A | 48,220 | D | |
| Common Stock | Nov 2, 2015 | S | 23,216 | $24.2944 | D | 25,004 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $0.57 | Nov 2, 2015 | M | 23,216 | D | — | Aug 30, 2016 | Common Stock | 23,216 | 0 | D |
Explanation of responses
- F1This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F3Immediately.